Interleukin-11 administration normalizes the platelet count in hypersplenic cirrhotic patient

C. Ustun, P. M. Dainer, G. B. Faguet

Research output: Contribution to journalArticle

8 Scopus citations


We report the successful administration of interleukin-11 (IL-11 or oprelvekin), a promoter of megakaryocyte maturation, to a 54-year-old male Jehovah's Witness with hepatic cirrhosis and hypersplenic thrombocytopenia requiring surgery for symptomatic interstitial cystitis. This observation suggests that oprelvekin might be crucial in the acute management of certain types of hypersplenic thrombocytopenias.

Original languageEnglish (US)
Pages (from-to)609-610
Number of pages2
JournalAnnals of Hematology
Issue number10
Publication statusPublished - Dec 1 2002



  • Hypersplenism
  • Interleukin-11
  • Neumega
  • Oprelvekin
  • Thrombocytopenia

ASJC Scopus subject areas

  • Hematology

Cite this